On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for ...

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

Novavax said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency ...

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

3, KP.3.1.1 and LB.1. 1 In clinical trials, the most common adverse reactions associated with Novavax's prototype COVID-19 vaccine (NVX-CoV2373) included headache, nausea or vomiting, muscle pain ...

Without explicitly naming the alternative — Novavax — the Sept. 12 guidance appeared to reluctantly endorse that vaccine for ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

Novavax Gets EU Authorization for Updated COVID Vaccine Targeting JN.1 Strain (Reuters) -The European Commission authorized Novavax's updated COVID-19 vaccine targeting the JN.1 strain of ...

Novavax: The Novavax was the fourth COVID vaccine to be administered in the U.S., after Johnson & Johnson, which is no longer available. The Novavax vaccine is the only non-mRNA updated COVID ...

Oct 9 (Reuters) - The European Commission authorized Novavax's (NVAX.O), opens new tab updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, the company said on Wednesday.